Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Cytochrome P450 1A2 Inducers [MoA]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Drug	Reports	Deaths	Death Rate	Hosp.	Life-Threat.	Avg Age	% Female
OSIMERTINIB	27,750	12,456	44.9%	5,277	757	68.2 yrs	66.0%
CARBAMAZEPINE	24,577	2,156	8.8%	9,608	1,705	50.1 yrs	61.8%
PHENYTOIN	14,469	1,449	10.0%	5,241	1,087	46.5 yrs	50.7%
RITONAVIR	11,980	1,190	9.9%	2,925	350	43.8 yrs	43.8%
FOSPHENYTOIN	1,378	166	12.0%	646	261	37.5 yrs	52.4%

Head-to-Head Comparisons

OSIMERTINIB vs CARBAMAZEPINE OSIMERTINIB vs PHENYTOIN OSIMERTINIB vs RITONAVIR OSIMERTINIB vs FOSPHENYTOIN CARBAMAZEPINE vs PHENYTOIN CARBAMAZEPINE vs RITONAVIR CARBAMAZEPINE vs FOSPHENYTOIN PHENYTOIN vs RITONAVIR PHENYTOIN vs FOSPHENYTOIN RITONAVIR vs FOSPHENYTOIN

← Back to Cytochrome P450 1A2 Inducers [MoA] Class side effects →